Preparation and biological evaluation of cyclopentadienyl-based 99mTc-complexes [(Cp-R)99mTc(CO)3] mimicking benzamides for malignant melanoma targeting
- 1 April 2010
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 37 (3) , 255-264
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Nouveaux traceurs TEMP : exemple des traceurs des protéoglycanes et de la mélanineMédecine Nucléaire, 2009
- Phase I/II Trial of Tremelimumab in Patients With Metastatic MelanomaJournal of Clinical Oncology, 2009
- Ultra-structural cell distribution of the melanoma marker iodobenzamide: improved potentiality of SIMS imaging in life sciencesBioMedical Engineering OnLine, 2004
- Metals in MedicineAngewandte Chemie International Edition, 1999
- Synthesis, In Vitro Binding, and Tissue Distribution of Radioiodinated 2-[125I]N-(N-Benzylpiperidin-4-yl)-2-Iodo Benzamide, 2-[125I]BP: A Potential σ Receptor Marker for Human Prostate TumorsNuclear Medicine and Biology, 1998
- Technetium Radiopharmaceuticals—Fundamentals, Synthesis, Structure, and DevelopmentAngewandte Chemie International Edition, 1994
- Synthesis and Characterization of [125I]-N-(N-Benzylpiperidin-4-yl)-4-iodobenzamide, a New .sigma. Receptor Radiopharmaceutical: High-Affinity Binding to MCF-7 Breast Tumor CellsJournal of Medicinal Chemistry, 1994
- Accumulation of 125I-labelled thiouracil and propylthiouracil in murine melanotic melanomasBritish Journal of Cancer, 1982
- Melanoma affine radiopharmaceuticalsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1981
- Accumulation of radioiodinated tyrosine derivatives in the adrenal medulla and in melanomasEuropean Journal of Nuclear Medicine and Molecular Imaging, 1979